It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol Hill purple at the 2026 National Lupus Advocacy Summit this April!
In the United States, SLE remains associated with substantial mortality, particularly among Non-Hispanic Black women.
A new study found that people with cytomegalovirus (CMV) infection may be more likely to develop systemic lupus erythematosus (SLE), and CMV could influence how the disease starts.
Social determinants of health were associated with increased risks for organ damage and mortality among patients with lupus.
Patients with systemic lupus erythematosus who receive belimumab monotherapy show comparable remission rates and disease control to those who receive combination therapy with immunosuppressants.
US FDA Rejects AstraZeneca's Easier-to-use Version Of Lupus Therapy AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an ...
Systemic lupus erythematosus (SLE) is an autoimmune disease, in which the immune system that normally protects the body from invading microbes turns against the body's own cells. Researchers studied ...
Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), showed efficacy in adults with active systemic lupus erythematosus (SLE) ...
The systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the seven major markets (7MM: the USA, France, ...
A growth in the systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the 7MM is anticipated, as per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results